Common Equity: The sum of all common equity items.
Jupiter Neurosciences, Inc. (JUNS) had Common Equity of $-1.83M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.02M |
|
$-8.64M |
|
$0.00M |
|
$0.02M |
|
$8.93M |
|
$-8.91M |
|
$0.26M |
|
$-8.64M |
|
$-8.64M |
|
$-8.64M |
|
$-8.64M |
|
$-8.64M |
|
$-8.64M |
|
$-8.91M |
|
$-8.91M |
|
34.63M |
|
34.63M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$4.83M |
|
-- |
|
$0.74M |
|
$5.56M |
|
$7.40M |
|
-- |
|
-- |
|
$7.40M |
|
|
Common Equity |
$-1.83M |
$-1.83M |
|
$-1.83M |
|
34.45M |
|
| Cash Flow Statement Financials | |
$-5.41M |
|
-- |
|
$5.43M |
|
$3.77M |
|
$3.79M |
|
$0.02M |
|
$2.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.65 |
|
-- |
|
-- |
|
-- |
|
-2.89 |
|
80.59% |
|
-40873.20% |
|
-40873.20% |
|
-40873.20% |
|
-39662.77% |
|
-39662.77% |
|
$-5.41M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.03 |
|
8.27 |
|
44.16 |
|
471.92% |
|
471.92% |
|
-155.37% |
|
471.92% |
|
$-0.05 |
|
$-0.16 |
|
$-0.16 |
|